Liver Organoid Research: Present Situation, limiting Factors and Future Therapeutical Potential in Pediatric Diseases

References (48)

1. 1 Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids [DOI]
2. 2 Multilineage communication regulates human liver bud development from pluripotency [DOI]
3. 3 Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation [DOI]
4. 4 Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells [DOI]
5. 5 Cholangiocyte organoids can repair bile ducts after transplantation in the human liver [DOI]
6. 6 Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant [DOI]
7. 7 Modelling human hepato-biliary-pancreatic organogenesis from the foregut–midgut boundary [DOI]
8. 8 Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids [DOI]
9. 9 Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids [DOI]
10. 10 Engineering Organoid Vascularization [DOI]
11. 11 Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance [DOI]
12. 12 Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury [DOI]
13. 13 Present status and perspectives of cell-based therapies for liver diseases [DOI]
14. 14 In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease [DOI]
15. 15 A Chemically Defined Hydrogel for Human Liver Organoid Culture [DOI]
16. 16 Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells [DOI]
17. 17 Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling [DOI]
18. 18 Molecular Obstacles to Clinical Translation of iPSCs [DOI]
19. 19 Large‐Scale Production of LGR5‐Positive Bipotential Human Liver Stem Cells [DOI]
20. 20 In vivo and ex vivo methods of growing a liver bud through tissue connection [DOI]
21. 21 Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells [DOI]
22. 22 Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells [DOI]
23. 23 Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure [DOI]
24. 24 Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling [DOI]
25. 25 Human iPSC-Derived Posterior Gut Progenitors Are Expandable and Capable of Forming Gut and Liver Organoids [DOI]
26. 26 FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma [DOI]
27. 27 Lgr5+ stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool [DOI]
28. 28 Organoid Center Strategies for Accelerating Clinical Translation [DOI]
29. 29 Long-Term Survival of Transplanted Autologous Canine Liver Organoids in a COMMD1-Deficient Dog Model of Metabolic Liver Disease [DOI]
30. 30 Progress in human liver organoids [DOI]
31. 31 Liver sinusoidal endothelial cells promote the differentiation and survival of mouse vascularised hepatobiliary organoids [DOI]
32. 32 Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors [DOI]
33. 33 Cell Aggregation Culture Induces Functional Differentiation of Induced Hepatocyte-like Cells through Activation of Hippo Signaling [DOI]
34. 34 Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro [DOI]
35. 35 Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model [DOI]
36. 36 The Regenerative Effect of Portal Vein Injection of Liver Organoids by Retrorsine/Partial Hepatectomy in Rats [DOI]
37. 37 Generation of human induced pluripotent stem cell-derived liver buds with chemically defined and animal origin-free media [DOI]
38. 38 Bioartificial Liver: Its Pros and Cons [DOI]
39. 39 Advances in cell sources of hepatocytes for bioartificial liver [DOI]
40. 40 Transplantation of Liver Organoids in the Omentum and Kidney [DOI]
41. 41 Randomized Controlled Study of Plasma Exchange Combined With Molecular Adsorbent Re-Circulating System for the Treatment of Liver Failure Complicated with Hepatic Encephalopathy [DOI]
42. 42 Direct orthotopic implantation of hepatic organoids [DOI]
43. 43 Reconstruction of hepatic organoid by hepatic stem cells [DOI]
44. 44 Establishment of Human Leukocyte Antigen-Mismatched Immune Responses after Transplantation of Human Liver Bud in Humanized Mouse Models [DOI]
45. 45 Frontiers in Bioengineering and Biotechnology [DOI]
46. 46 Therapeutic Apheresis and Dialysis [DOI]
47. 47 Scalable production of tissue-like vascularised liver organoids from human PSCs [DOI]
48. 48 Phase 1/2a Trial of a Bioartificial Liver Support System (LifeLiver) for Acute Liver Failure Patients [DOI]

Cited by 0

No indexed citations yet.

Related research

• Effects of Hydro-ethanolic Leaf Extract of Tithonia diversifolia on Parasitaemia Level, Serum Metabolites and Histopathology of Organs in Swiss Albino Mice Infected with Plasmodium berghei NK65 — shares topic coverage
• Common Findings in Ultrasound Examination of the Liver and Kidney in Sokoto Metropolis — shares topic coverage
• Liver Profile of Artemether-lumefantrine-tinidazole in Healthy and Parasitized Mice — shares topic coverage
• Sonographic Assessment of Maternal Portal Vein Diameter in Healthy Pregnancy in South-South Nigeria — shares topic coverage
• Quadruple Arterial Blood Supply to the Liver: A Rare Variation — shares topic coverage